Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021).

Saved in:
Bibliographic Details
Title: Trends in the activity of mold-active azole agents against Aspergillus fumigatus clinical isolates with and without cyp51 alterations from Europe and North America (2017-2021).
Authors: Pfaller MA; JMI Laboratories , North Liberty, Iowa, USA.; University of Iowa , Iowa City, Iowa, USA., Carvalhaes CG; JMI Laboratories , North Liberty, Iowa, USA., Rhomberg PR; JMI Laboratories , North Liberty, Iowa, USA., Desphande LM; JMI Laboratories , North Liberty, Iowa, USA., Castanheira M; JMI Laboratories , North Liberty, Iowa, USA.
Source: Journal of clinical microbiology [J Clin Microbiol] 2024 Feb 14; Vol. 62 (2), pp. e0114123. Date of Electronic Publication: 2024 Jan 09.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 7505564 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-660X (Electronic) Linking ISSN: 00951137 NLM ISO Abbreviation: J Clin Microbiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-660X
DOI:10.1128/jcm.01141-23